Skip to main content

Home/ medindia/ Group items tagged 2

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Alex Parker

GlaxoSmithKline's Tanzeum gets FDA approval for type 2 diabetes treatment - 1 views

drugdelivery.pharmaceutical-business-review.com/...betes-treatment-160414-4215125

health news medical pharma

shared by Alex Parker on 16 Apr 14 - No Cached
  • Alex Parker on 16 Apr 14
     
    GSK has received approval from FDA for its Tanzeum subcutaneous injection to improve glycemic control, along with diet and exercise, in adult patients with type 2 diabetes.
med india

Crigler-Najjar Syndrome-Causes-Risk Factors-Symptoms-Diagnosis-Treatment-Complications ... - 0 views

www.medindia.net/...crigler-najjar-syndrome.htm

Crigler-Najjar syndrome type 1 2 arias pathological jaundice race age cause enzyme deficiency glucuronosyl transferase autosomal recessive CNS medindia

shared by med india on 04 Nov 11 - No Cached
  • med india on 04 Nov 11
     
    Crigler-Najjar syndrome arises due to the lack or deficiency of the enzyme uridine diphosphate glucuronosyl transferase. Type 1 and type 2 forms of the disease have been described.
Alex Parker

GlaxoSmithKline's once-weekly diabetes drug Eperzan gets marketing approval in Europe - 1 views

drugdelivery.pharmaceutical-business-review.com/...roval-in-europe-270314-4204343

health news medical pharma

shared by Alex Parker on 27 Mar 14 - No Cached
  • Alex Parker on 27 Mar 14
     
    PBR Staff Writer Published 27 March 2014 The European Commission (EC) has granted marketing authorization for GlaxoSmithKline's (GSK's) once-weekly diabetes treatment, Eperzan (albiglutide). The drug is indicated for the treatment of type 2 diabetes mellitus in adults, to improve glucose control as monotherapy, when diet and exercise alone do not provide adequate glycaemic control in patients for whom the use of metformin is considered inappropriate due to contraindications or intolerance.
1 - 3 of 3
Showing 20▼ items per page